Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

6.8%

3 terminated out of 44 trials

Success Rate

86.4%

-0.1% vs benchmark

Late-Stage Pipeline

11%

5 trials in Phase 3/4

Results Transparency

47%

9 of 19 completed with results

Key Signals

9 with results86% success

Data Visualizations

Phase Distribution

36Total
Not Applicable (23)
P 1 (3)
P 2 (5)
P 3 (2)
P 4 (3)

Trial Status

Completed19
Recruiting8
Active Not Recruiting6
Terminated3
Unknown3
Enrolling By Invitation2

Trial Success Rate

86.4%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (44)

Showing 20 of 20 trials
NCT05914649Not ApplicableRecruitingPrimary

NC Testing in LC & POTS

NCT04881318Not ApplicableRecruitingPrimary

Compression Garments in the Community With POTS

NCT05924646Not ApplicableRecruitingPrimary

CAlgary SAlt for POTS

NCT05363514Phase 4Not Yet RecruitingPrimary

Low Dose Naltrexone Use in Patients With POTS

NCT05555771Not ApplicableRecruiting

Paediatric Syncope in the Emergency Department

NCT05633693Not ApplicableRecruiting

Postural Sway and Counterpressure Maneuvers for Pediatric Syncope

NCT06133075Phase 2CompletedPrimary

Using Mirabegron to Increase BP in Patients With POTS

NCT02281097Not ApplicableActive Not RecruitingPrimary

Transdermal Vagal Stimulation for POTS

NCT05212129Not ApplicableRecruiting

Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome

NCT05344599Active Not RecruitingPrimary

Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome

NCT00962728Not ApplicableActive Not Recruiting

Breathing Device in Postural Orthostatic Tachycardia Syndrome (POTS)

NCT02725060Not ApplicableEnrolling By InvitationPrimary

Autoimmune Basis for Postural Tachycardia Syndrome

NCT06268288Not ApplicableCompleted

Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Syndrome (POTS)

NCT02196376Active Not RecruitingPrimary

Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome

NCT00608725Not ApplicableActive Not Recruiting

Pathophysiology of Orthostatic Intolerance

NCT06292104RecruitingPrimary

Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)

NCT05633407Phase 2CompletedPrimary

Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS

NCT05741112Not ApplicableRecruiting

The Long COVID-19 Wearable Device Study

NCT05094622Not ApplicableActive Not Recruiting

Physical Training in Patients With POTS After Covid-19

NCT05454137Not ApplicableCompletedPrimary

A Shared Medical Appointment Intervention for Quality of Life Improvement in POTS

Scroll to load more

Research Network

Activity Timeline